Cargando…
Adjuvant chemotherapy in carcinoma colon: Is there a rationale to change practice for Asian patients?
Autores principales: | Rangarajan, Bharath, Binoy, Vineetha, Hingmire, Sachin Sharatchandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892511/ https://www.ncbi.nlm.nih.gov/pubmed/24455573 http://dx.doi.org/10.4103/2278-330X.114096 |
Ejemplares similares
-
Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014) -
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
por: Hingmire, Sachin S., et al.
Publicado: (2017) -
In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023) -
Regarding “Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs”
por: Su, I-Hsuan, et al.
Publicado: (2023) -
Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)